Meng Fansu, Lai Haibiao, Luo Zekun, Liu Yong, Huang Xiaoxun, Chen Junqian, Liu Bayi, Guo Yingjun, Cai Yu, Huang Qingqing
Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of TCM, Zhongshan, Guangdong 528400, China.
Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine and Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510006, China.
Evid Based Complement Alternat Med. 2018 Sep 9;2018:2939307. doi: 10.1155/2018/2939307. eCollection 2018.
Xuefu Zhuyu Decoction (XFZYD), the classical recipe for promoting blood circulation by removing blood stasis, has been used in China for a long history clinically. XFZYD has been found to improve cardiac function through reducing inflammation. However, the effect of XFZYD on myocardial apoptosis remains unclear. Herein, we investigated the mechanism of XFZYD preconditioning on myocardial injury in sepsis rats. The rats were treated with XFZYD one week, followed with intraperitoneal injection of lipopolysaccharide (LPS: 10 mg/kg) to induce sepsis. Pretreatment with XFZYD could reverse the effects of LPS-induced decreased mean arterial pressure (MAP) and increased heart rate (HR). XFZYD decreased the levels of malondialdehyde (MDA), superoxide dismutase (SOD), tumor necrosis factor- (TNF-), interleukin-1 (IL-1), and interleukin-6 (IL-6) in serum or in heart. TUNEL staining revealed that the apoptotic index of XFZYD was significantly lower compared with the LPS group (P<0.05). Western blot results showed that the high doses of pretreatment XFZYD group can reduce the Bax expression of myocardial tissue in rats (P<0.05, P<0.01). The expression of Bcl-2 in XFZYD group was significantly higher than that in the LPS group (P<0.01), while the expression of caspase-3 in treatment group was significantly lower than that in the LPS group only after 12 h modeling (P<0.01). In addition, caspase-3 activity in rat cardiomyocytes of XFZYD-treated animals was significantly decreased. These findings suggest that pretreatment with XFZYD exerts a protective effect in the myocardium of septic rats by inhibiting myocardial cell apoptosis and antioxidation.
血府逐瘀汤(XFZYD)是活血化瘀的经典方剂,在中国临床应用已有很长历史。已发现血府逐瘀汤可通过减轻炎症来改善心脏功能。然而,血府逐瘀汤对心肌细胞凋亡的影响仍不清楚。在此,我们研究了血府逐瘀汤预处理对脓毒症大鼠心肌损伤的机制。大鼠连续一周接受血府逐瘀汤治疗,随后腹腔注射脂多糖(LPS:10mg/kg)诱导脓毒症。血府逐瘀汤预处理可逆转LPS诱导的平均动脉压(MAP)降低和心率(HR)增加的作用。血府逐瘀汤降低了血清或心脏中丙二醛(MDA)、超氧化物歧化酶(SOD)、肿瘤坏死因子-(TNF-)、白细胞介素-1(IL-1)和白细胞介素-6(IL-6)的水平。TUNEL染色显示,与LPS组相比,血府逐瘀汤组的凋亡指数显著降低(P<0.05)。蛋白质印迹结果显示,高剂量血府逐瘀汤预处理组可降低大鼠心肌组织中Bax的表达(P<0.05,P<0.01)。血府逐瘀汤组Bcl-2的表达显著高于LPS组(P<0.01),而仅在建模12小时后,治疗组caspase-3的表达显著低于LPS组(P<0.01)。此外,血府逐瘀汤处理的动物大鼠心肌细胞中的caspase-3活性显著降低。这些结果表明,血府逐瘀汤预处理通过抑制心肌细胞凋亡和抗氧化作用对脓毒症大鼠的心肌发挥保护作用。